Spermosens (SPERM)

Spermosens are active in medical technology. The company specializes in the development of medical devices. The product portfolio is broad and includes products for male infertility and individually tailored fertility treatments. Research and development is conducted via its own technological platform that analyzes sperm quality, which is further used for medical data and potential fertilization. The largest operations are in the Nordic market.

Quotes for Spermosens AB (publ)

Right Now

+/-: 0.0002
%: 3,23%
Latest: 0.0064
High: 0.0064
Low: 0.0058
Volume: 42 959 771
Turnover (SEK): 258 940
Market Value (MSEK): 20,3
Time (Latest trade)

Board

CEO

Tore Duvold

Chairperson of the Board

Ulrik Spork

Board

Christina Östberg Lloyd
Ingela Liljeqvist Soltic
Kushagr Punyani
Sören Melsing Frederiksen

News

2025-06-17 14:16:07 Spermosens announces outcome of exercise of warrants series TO 5
2025-06-16 11:15:42 Spermosens AB Announces Results from Annual General Meeting on 16 June 2025
2025-06-13 13:04:02 Chairman and CEO of Spermosens exercise TO5 warrants
2025-06-11 12:48:55 Spermosens concludes clinical study with statistically significant results supporting the diagnostic value of JUNO-Checked
2025-06-05 21:09:15 The capital raise and issue announced in March 2025 is approved by Inspectorate of Strategic Products

News agencies

2025-06-17 14:29:17 Finwire: Spermosens tillförs 2,6 miljoner kronor från utnyttjande av teckningsoptioner
2025-06-13 14:15:25 Finwire: Spermosens ordförande och vd utnyttjar teckningsoptioner för att teckna aktier (R)
2025-06-13 13:18:14 Finwire: Spermosens vd och finanschef utnyttjar teckningsoptioner för att teckna aktier
2025-06-11 12:59:31 Finwire: Spermosens når statistiskt signifikanta resultat i klinisk studie
2025-06-02 09:17:28 Finwire: Spermosens fastställer teckningskurs för TO5

Largest Owners

Name	Capital %	Votes %	Date
Mount Nebo Capital	24,95	24,95	2025-03-04
Avanza Pension	12,40	12,40	2025-06-26
Nordnet Pensionsförsäkring	9,71	9,71	2025-06-26
UNITY Innovation Alliance AG	5,17	5,17	2025-03-04
Henrik Ruö Jensen	3,76	3,76	2025-06-26
Michael Kantor	3,46	3,46	2025-06-26
Peter Nilsson	3,33	3,33	2025-06-26
Flexmedical Solutions Limited	3,08	3,08	2025-03-31
John Moll	2,59	2,59	2025-06-26
Per Robert Anderson	2,36	2,36	2025-06-26

** Holdings by Modular Finance AB. Compiled and processed data from various sources, including Euroclear, Morningstar and the Swedish Financial Supervisory Authority.

Insider trading

Ulrik Nilsson	2024-12-23	Sell Transaction	Spermosens	- 4 400 006	0,01	−50 160,1	SEK
Ulrik Nilsson	2024-04-17	en-US	SPERM BTU	250 000	0,7	175 000,0	SEK
Eva Nilsagård	2024-04-17	en-US	SPERM BTU	102 000	0,7	71 400,0	SEK
Ulrik Nilsson	2023-05-29	Buy Transaction	Spermosens	68 100	0,69	46 989,0	SEK
Kushagr Punyani	2023-01-30	en-US	BTU	59 524	0,84	50 000,2	SEK
Søren Melsing Frederiksen	2023-01-25	en-US	BTU	175 000	0,84	147 000,0	SEK
John Lempert	2023-01-23	en-US	Spermosens UR	23 808	0,84	19 998,7	SEK
Ulrik Nilsson	2023-01-23	en-US	Spermosens BTU	128 400	0,84	107 856,0	SEK
Eva Nilsagård	2023-01-23	en-US	Spermosens BTU	72 000	0,84	60 480,0	SEK
John Lempert	2023-01-23	en-US	Spermosens UR	9 920	0,84	8 332,8	SEK
Kushagr Punyani	2023-01-18	Sell Transaction	Spermosens UR	- 47 500	0,14	−6 650,0	SEK
Kushagr Punyani	2023-01-16	Sell Transaction	Spermosens UR	- 250 000	0,11	−27 500,0	SEK
Kushagr Punyani	2023-01-18	Sell Transaction	Spermosens UR	- 110 000	0,17	−18 700,0	SEK
Kushagr Punyani	2023-01-18	Sell Transaction	Spermosens UR	- 90 000	0,17	−15 300,0	SEK
Kushagr Punyani	2023-01-18	Sell Transaction	Spermosens UR	- 78 369	0,17	−13 322,7	SEK
Kushagr Punyani	2023-01-18	Sell Transaction	Spermosens UR	- 70 000	0,17	−11 900,0	SEK
Kushagr Punyani	2023-01-18	Sell Transaction	Spermosens UR	- 62 000	0,24	−14 880,0	SEK
Kushagr Punyani	2023-01-16	Sell Transaction	Spermosens UR	- 60 000	0,15	−9 000,0	SEK
Kushagr Punyani	2023-01-18	Sell Transaction	Spermosens UR	- 50 000	0,2	−10 000,0	SEK
Kushagr Punyani	2023-01-18	Sell Transaction	Spermosens UR	- 50 000	0,14	−7 000,0	SEK
Kushagr Punyani	2023-01-16	Sell Transaction	Spermosens UR	- 50 000	0,14	−7 000,0	SEK
Kushagr Punyani	2023-01-18	Sell Transaction	Spermosens UR	- 45 000	0,24	−10 800,0	SEK
Kushagr Punyani	2023-01-18	Sell Transaction	Spermosens UR	- 40 000	0,17	−6 800,0	SEK
Kushagr Punyani	2023-01-18	Sell Transaction	Spermosens UR	- 30 000	0,24	−7 200,0	SEK
Kushagr Punyani	2023-01-18	Sell Transaction	Spermosens UR	- 30 000	0,13	−3 900,0	SEK
Kushagr Punyani	2023-01-16	Sell Transaction	Spermosens UR	- 26 500	0,13	−3 445,0	SEK
Kushagr Punyani	2023-01-18	Sell Transaction	Spermosens UR	- 6 322	0,22	−1 390,8	SEK
Kushagr Punyani	2023-01-16	Sell Transaction	Spermosens UR	- 22 600	0,12	−2 712,0	SEK
Kushagr Punyani	2023-01-16	Sell Transaction	Spermosens UR	- 19 949	0,15	−2 992,3	SEK
Ulrik Nilsson	2022-06-22	en-US	Personaloptionsprogram 2022/2025	190 000	0	0,0	SEK
John Lempert	2022-05-25	en-US	Spermosens	- 25 000	0	−0,0	SEK
John Lempert	2022-05-25	en-US	Spermosens	35 524	12,29	436 590,0	SEK
John Lempert	2022-05-25	en-US	Spermosens TO1	- 35 524	0	−0,0	SEK
Ulrik Nilsson	2022-05-25	en-US	Spermosens	10 000	12,29	122 900,0	SEK
Ulrik Nilsson	2022-05-25	en-US	Spermosens	25 000	0	0,0	SEK
Ulrik Nilsson	2022-05-25	en-US	Spermosens TO1	- 10 000	0	−0,0	SEK
Ulrik Nilsson	2022-05-04	Buy Transaction	Spermosens TO1	10 000	0,4	4 000,0	SEK
Mosike Thabitha Carlsson	2021-05-17	Buy Transaction	Spermosens	650	9,15	5 947,5	SEK
Mosike Thabitha Carlsson	2021-05-21	Buy Transaction	Spermosens	5 000	8,96	44 800,0	SEK
Eva Nilsagård	2021-05-10	Buy Transaction	Spermosens	30 000	9,9	297 000,0	SEK
Cajsa Wramdemark	2021-05-07	en-US	Spermosens	3 995	5,63	22 491,8	SEK
Cajsa Wramdemark	2021-04-30	en-US	SPERMOSENS/SH	8 881	5,63	50 000,0	SEK
Søren Melsing Frederiksen	2021-04-21	en-US	Spermosens	169 132	5,63	952 213,2	SEK
John Moll	2021-04-16	en-US	Spermosens	37 766	5,63	212 622,6	SEK
John Moll	2021-04-19	en-US	Spermosens	37 300	5,63	209 999,0	SEK
John Lempert	2021-04-15	en-US	Spermosens	25 524	5,63	143 700,1	SEK
Oscar Nilsagård	2021-04-16	en-US	Spermosens	3 000	5,63	16 890,0	SEK

*Source: Holdings by Modular Finance AB. Compiled and processed data from the Swedish Financial Supervisory Authority

Key Numbers

Number of months that the report spans	Q1 3 Months	2024	Q4 3 Months	Q3 3 Months	Q2 3 Months	Q1 3 Months	2023
Total revenue MSEK	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Earnings before interest and tax MSEK	-2.06	-9.16	-2.37	-2.13	-2.06	-2.60	-10.87
Profit before tax MSEK	-2.07	-10.20	-2.46	-2.16	-2.37	-3.22	-12.20
Net profit MSEK	-2.07	-10.20	-2.46	-2.16	-2.37	-3.22	-12.20
Earnings per share SEK	-0.00	-0.00	-0.00	-0.00	-0.00	-0.00	-0.00
Dividend per share SEK		0.00					0.00
Equity MSEK	38.10	27.35	27.35	21.97	24.13	8.82	12.69
Fixed assets MSEK	0.42	0.46	0.46	0.52	0.56	0.61	0.65
Intangible assets MSEK	24.91	24.34	24.34	23.74	22.84	21.47	19.74
Current assets MSEK	3.81	1.76	1.76	0.74	3.90	1.74	5.72
Total asset MSEK	39.94	31.04	31.04	25.00	27.30	23.82	26.11
Long term liabilities MSEK	0.00	0.00	0.00	0.03	0.05	0.08	0.23
Current liabilities MSEK	1.84	3.70	3.70	2.99	3.12	15.00	13.18
Number of shares SEK	1356.18	283.61	283.61	283.61	283.61	41.19	41.19

*Compiled data from Millistream

Upcoming reports

2025-08-20 Delårsrapport 2025-Q2
2025-11-12 Delårsrapport 2025-Q3

Spermosens AB (publ)